Atom Therapeutics
China - SuzhouBiotechnology
Focus: Atom Therapeutics is a China-based biotech company focused on developing small-molecule therapeutics for metabolic diseases, particularly gout. Founded in 2012 and currently at Series C+ stage, the company is building a targeted pipeline in a high-prevalence disease area.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES C +
Open Jobs
0
About Atom Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Atom Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ABP-745
GoutClinical Trials (3)
NCT07303777Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
Phase 2Help build intelligence for Atom Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.